Revvityブログ
発見から治療までのイノベーションを促進
Latest
Decoding tirzepatide’s dual agonism with advanced pharmacology assays.
Assay Development Workflows
January 8, 2026 - 7 min read
NGS
Automated normalization of small RNA libraries with AutoNorm™ technology.
January 7, 2026 -
1 min read
NGS
Enhancing whole blood RNA-seq with globin depletion strategies.
December 31, 2025 -
3 min read
Cell Signaling Analysis
Study reveals multifaceted roles of β-arrestins in GPCR internalization, including GLP-1R.
December 22, 2025 -
5 min read
Cell and Gene Therapy
Addressing technical barriers in primary T cell research.
December 19, 2025 -
4 min read
Cell and Gene Therapy
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
December 8, 2025 -
5 min read
Cancer
Enhancing CAR NK-cell research with chemically defined serum-free culture solutions.
December 5, 2025 -
3 min read
NGS
Programmable depletion with CRISPR–Cas9: what DASH is, why it works, and where to use it.
December 2, 2025 -
4 min read
Disease Research
What to consider when scaling tissue lysis workflows for multi-analyte DNA/RNA workstreams.
December 1, 2025 -
4 min read
NGS
Variant calling through bulk RNA-seq is growing up: implications for oncology introduction.
December 1, 2025 -
3 min read
NGS
Next GeneSiS: cfDNA sequencing outperforms blood culture in sepsis.
December 1, 2025 -
4 min read
